1. Zhao, Shan-Chao, Zhou, Bo-Wei, Luo, Fei, Mao, Xueying, Lu, Yong-Jie. 2015. The structure and function of NKAIN2-a candidate tumor suppressor. In International journal of clinical and experimental medicine, 8, 17072-9. doi:. https://pubmed.ncbi.nlm.nih.gov/26770299/
2. Mao, Xueying, Luo, Fei, Boyd, Lara K, Zhao, Shan-Chao, Lu, Yong-Jie. . NKAIN2 functions as a novel tumor suppressor in prostate cancer. In Oncotarget, 7, 63793-63803. doi:10.18632/oncotarget.11690. https://pubmed.ncbi.nlm.nih.gov/27588475/
3. Romania, Paolo, Castellano, Aurora, Surace, Cecilia, Locatelli, Franco, Fruci, Doriana. 2013. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma. In PloS one, 8, e78481. doi:10.1371/journal.pone.0078481. https://pubmed.ncbi.nlm.nih.gov/24205241/
4. Asai, Akiko, Karnan, Sivasundaram, Ota, Akinobu, Yokoo, Kazuhisa, Hosokawa, Yoshitaka. 2015. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas. In Gene, 558, 220-6. doi:10.1016/j.gene.2014.12.064. https://pubmed.ncbi.nlm.nih.gov/25562418/
5. Edwards, Alexis C, Bigdeli, Tim B, Docherty, Anna R, Riley, Brien P, Fanous, Ayman H. 2015. Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. In Schizophrenia bulletin, 42, 279-87. doi:10.1093/schbul/sbv119. https://pubmed.ncbi.nlm.nih.gov/26316594/
6. Zhao, Yilu, Fu, Zhao, Barnett, Eric J, Faraone, Stephen V, Yang, Li. 2025. Genome data based deep learning identified new genes predicting pharmacological treatment response of attention deficit hyperactivity disorder. In Translational psychiatry, 15, 46. doi:10.1038/s41398-025-03250-5. https://pubmed.ncbi.nlm.nih.gov/39920114/
智鼠故事 
